CELL-EASY announces the completion of a financing round, with MxEP as lead investor and reference shareholder

Published on
5 months ago
Body

Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development. 

Content